EKF Diagnostics Holdings plc (OTCMKTS:EKDHF – Get Free Report) shares dropped 2.7% on Wednesday . The company traded as low as $0.34 and last traded at $0.34. 20,000 shares changed hands during mid-day trading, an increase of 0% from the average session volume of 20,000 shares. The stock had previously closed at $0.3496.
EKF Diagnostics Trading Down 2.7%
The company’s fifty day moving average price is $0.35 and its 200-day moving average price is $0.34.
About EKF Diagnostics
EKF Diagnostics Holdings plc (OTCMKTS: EKDHF) is a global in vitro diagnostics company that develops, manufactures and markets a broad range of point-of-care and laboratory analyzers, reagents and consumables. The company’s product portfolio addresses key segments of the diagnostic testing market, including haematology, biochemistry, immunoassay, haemostasis and diabetes monitoring.
EKF Diagnostics offers peripheral blood analyzers designed for use in clinical laboratories, hospitals and veterinary clinics, along with handheld and benchtop devices for rapid on-site testing.
See Also
- Five stocks we like better than EKF Diagnostics
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
